[u'Moraxella catarrhalis induces CEACAM3-Syk-CARD9-dependent activation of human granulocytes', ['A. Heinrich', 'K. A. Heyl', 'E. Klaile', 'M. M. Muller', 'T. E. Klassert', 'A. Wiessner', 'K. Fischer', 'R. R. Schumann', 'U. Seifert', 'K. Riesbeck', 'A. Moter', 'B. B. Singer', 'S. Bachmann', 'H. Slevogt'], u'2016-06-22T04:35:15Z', u"Human granulocytes were isolated from EDTA-treated peripheral blood taken from healthy volunteers using 1-Step\xae Polymorphs (Accuratechemical, NY, USA), according to the manufacturer's protocol. Granulocytes were then resuspended at 107\xa0cells ml\u22121\xa0in DMEM (Gibco, Life Technologies GmbH, Darmstadt, Germany). Donors signed a written informed consent form. This procedure was approved by the Ethics Committee of the Medical Faculty of the Charit\xe9 \u2013 Universit\xe4tsmedizin Berlin.", u'https://figshare.com/articles/Moraxella_catarrhalis_induces_CEACAM3-Syk-CARD9-dependent_activation_of_human_granulocytes/3457421', [u'Biotechnology', u'Cell Biology'], []]
[u'Lysophosphatidic acid induces YAP-promoted proliferation of human corneal endothelial cells via PI3K and ROCK pathways', ['Yi-Jen Hsueh', 'Hung-Chi Chen', 'Sung-En Wu', 'Tze-Kai Wang', 'Jan-Kan Chen', 'David Hui-Kang Ma'], u'2016-06-22T04:25:48Z', u'The isolation and culture of HCECs followed previous methods.52\xa0Briefly, after the central corneas had been used for corneal transplantation, the remaining corneoscleral tissues were rinsed three times with wash medium (containing Opti-MEM, 200 \u03bcg/ml gentamicin, and 10 \u03bcg/ml amphotericin B). Under a dissecting microscope, the trabecular meshwork was cleaned, and Descemet\u2019s membranes containing HCECs were stripped using forceps. Following digestion at 37 \xb0C for 24 hours with 0.5\u2009mg/ml collagenase A in wash medium, HCEC aggregates were collected via centrifugation at 495\u2009g for 8 minutes to remove the digestion solution and then cultured in 8-well Lab-Tek II chamber slides (Nalge Nunc International, Rochester, NY) coated with a fibronectin-collagen coating mix (AthenaES, Baltimore, MD) in HCEC growth medium, composed of Opti-MEM supplemented with 10% FBS, 20\u2009ng/ml hEGF, 10\u2009ng/ml FGF-basic, RPMI 1640 vitamin (1\xd7) solution (Sigma-Aldrich), 25 \xb5g/ml gentamicin, and 1.25 \xb5g/ml amphotericin B.', u'https://figshare.com/articles/Lysophosphatidic_acid_induces_YAP-promoted_proliferation_of_human_corneal_endothelial_cells_via_PI3K_and_ROCK_pathways/3457409', [u'Biotechnology', u'Cell Biology'], []]
[u'Leucine-Rich Repeat Kinase 2 Modulates Neuroinflammation and Neurotoxicity in Models of Human Immunodeficiency Virus 1-Associated Neurocognitive Disorders', ['Jenna M. Puccini', 'Daniel F. Marker', 'Tim Fitzgerald', 'Justin Barbieri', 'Christopher S. Kim', 'Patrick Miller-Rhodes', 'Shao-Ming Lu', 'Stephen Dewhurst', 'Harris A. Gelbard'], u'2016-06-22T04:03:51Z', u'Effects of LRRK2 kinase inhibition in primary microglia.\xa0A\u2013F, ICC of primary murine microglia for LRRK2 (green), CD11b (red), and DAPI (blue) after saline (A\u2013C) or Tat (D\u2013F) treatment with or without LRRK-IN-1 and GSK2578215A (40\xd7).\xa0G, Western blot of pS935\u2013LRRK2, total LRRK2, and \u03b2-actin protein levels 6 h after saline or Tat treatment with or without LRRK2-IN-1 and GSK2578215A.\xa0H, Tat-induced pS935\u2013LRRK2 is significantly decreased by LRRK2-IN-1 and GSK2578215A (**p\xa0< 0.01, one-way ANOVA with Newman\u2013Keuls\xa0post hoc\xa0test).', u'https://figshare.com/articles/Leucine-Rich_Repeat_Kinase_2_Modulates_Neuroinflammation_and_Neurotoxicity_in_Models_of_Human_Immunodeficiency_Virus_1-Associated_Neurocognitive_Disorders/3457406', [u'Biotechnology', u'Cell Biology'], []]
[u'Identification of Novel Death-Associated Protein Kinase 2 Interaction Partners by Proteomic Screening Coupled with Bimolecular Fluorescence Complementation', ['Jenna M. Puccini', 'Daniel F. Marker', 'Tim Fitzgerald', 'Justin Barbieri', 'Christopher S. Kim', 'Patrick Miller-Rhodes', 'Shao-Ming Lu', 'Stephen Dewhurst', 'Harris A. Gelbard'], u'2016-06-22T04:00:39Z', u'Effects of LRRK2 kinase inhibition in primary microglia.\xa0A\u2013F, ICC of primary murine microglia for LRRK2 (green), CD11b (red), and DAPI (blue) after saline (A\u2013C) or Tat (D\u2013F) treatment with or without LRRK-IN-1 and GSK2578215A (40\xd7).\xa0G, Western blot of pS935\u2013LRRK2, total LRRK2, and \u03b2-actin protein levels 6 h after saline or Tat treatment with or without LRRK2-IN-1 and GSK2578215A.\xa0H, Tat-induced pS935\u2013LRRK2 is significantly decreased by LRRK2-IN-1 and GSK2578215A (**p\xa0< 0.01, one-way ANOVA with Newman\u2013Keuls\xa0post hoc\xa0test).', u'https://figshare.com/articles/Identification_of_Novel_Death-Associated_Protein_Kinase_2_Interaction_Partners_by_Proteomic_Screening_Coupled_with_Bimolecular_Fluorescence_Complementation/3457400', [u'Biotechnology', u'Cell Biology'], []]
[u'Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer', ['Friederike Braig', 'Manuela Marz', 'Aneta Schieferdecker', 'Alexander Schulte', 'Mareike Voigt', 'Alexander Stein', 'Tobias Grob', 'Malik Alawi', 'Daniela Indenbirken', 'Malte Kriegs', 'Erik Engel', 'Udo Vanhoefer', 'Adam Grundhoff', 'Sonja Loges', 'Kristoffer Riecken', 'Boris Fehse', 'Carsten Bokemeyer', 'Mascha Binder'], u'2016-06-22T03:42:28Z', u'A:\xa0EGFR\xa0signaling in EGF-dependent Ba/F3 model. Wt and S492R or\xa0G465R\xa0mutant EGFR-expressing Ba/F3 cells were cultured in the presence or absence of EGF and with addition of cetuximab, panitumumab, rituximab or erlotinib. After 2 hours, cells were harvested and EGFR/pEGFR expression analyzed by western blot analysis. B: Sensitivity ofEGFR\xa0wt or\xa0EGFR G465R\xa0mutant-transfected Ba/F3 cells to treatment with EGFR-targeted antibodies. Ba/F3 cells were transformed to IL-3 independence with EGFR wt or mutant constructs and subsequently cultured in the presence or absence of EGF or with EGF in combination with panitumumab, cetuximab or control antibody rituximab. The number of viable cells was determined by trypan blue exclusion every 12 hours beginning 24 hours after seeding and plotted. Data are means from triplicate experiments +/\u2212SEM.', u'https://figshare.com/articles/Epidermal_growth_factor_receptor_mutation_mediates_cross-resistance_to_panitumumab_and_cetuximab_in_gastrointestinal_cancer/3457391', [u'Biotechnology', u'Cell Biology'], []]
[u'Figure 1', ['Tim Stinear', 'KYRA CHUA', 'ANDREW BUULTJENS', 'Sarah Louise Baines', 'Jason Kwong', 'Wei Gao', 'Mark Schultz', 'Zoe Cutcher', 'Stuart Adcock', 'Susan Ballard', 'TAKEHIRO TOMITA', 'NELA SUBASINGHE', 'GLEN CARTER', 'SACHA PIDOT', 'Lucinda Franklin', 'ANDERS GONCALVES DA SILVA', 'Torsten Seemann', 'BENJAMIN HOWDEN'], u'2016-06-22T02:03:06Z', u'Map of the greater Melbourne\narea, showing the location and year-of-occurrence of the eight legionellosis\noutbreaks, designated by codes A-H. Red circle shows the central Melbourne\nbusiness district. \u2018A\u2019 represents the location Melbourne aquarium aquarium\noutbreak and is close to centre of the Melbourne. Inset shows the location of\nMelbourne (red circle) within the State of Victoria in south east Australia.', u'https://figshare.com/articles/Figure_1/3457274', [u'Genomics', u'Microbial Ecology', u'Microbiology', u'Molecular Evolution'], []]
[u'Resetting Immunoglobulin Paratope Memory for the Recognition of Antigenically Varying Dengue Viral Serotypes to Prevent Antibodydependent Enhancement of Infection', ['Maurice Devaraj'], u'2016-06-21T18:05:05Z', u'The Dengue Virus (DENV)\ndoes not have any treatment or effective vaccine that can be used to target the\ninfection. Development of an effective treatment or vaccine is difficult due to\nAntibody Dependent Enhancement (ADE) of infection. As antibodies are responsible\nfor recognition of an infection, we attempt to understand the mechanism by\nwhich antibody memory is created. Based on a hypothesis for the process by\nwhich antibody memory is developed, we identify a method by which the memory\ncan be reset to be antigen non-specific, where the antibody\u2019s Paratope is\nunable to recognize the DENV antigen and reacts by forming a new structure in\nthe Paratope.', u'https://figshare.com/articles/Resetting_Immunoglobulin_Paratope_Memory_for_the_Recognition_of_Antigenically_Varying_Dengue_Viral_Serotypes_to_Prevent_Antibodydependent_Enhancement_of_Infection/3457082', [u'Infectious Diseases', u'Medicine', u'Virology'], []]
[u'Fig_8_behavior_temperature_bodyweight', ['stefan donath', 'Junfeng An', 'Karen Gertz', 'Anna Lena Datwyler', 'Ulrike Harms', 'Susanne Mueller', 'Tracy Farr', 'Gisela Lattig-Tunnemann', 'Janet Lips', 'Marco Foddis', 'Larissa Mosch', 'Rene Bernard', 'Ulrike Grittner', 'Mustafa Balkaya', 'Golo Kronenberg', 'Ulrich Dirnagl', 'Matthias  Endres', 'Christoph Harms'], u'2016-06-21T13:39:03Z', u'Mice were subjected to 30 min MCAo or sham surgery and TAT.b-Gal or TAT.ARC were administered in the contralateral ventricle after 3h after the onset of ischemia and mice were observed over 28 days. DeSimoni\nNeuroscore was performed at indicated time points (Fig. 8) as described (De Simoni et al., 2003; Orsini et al., 2012) with\nsome modifications. In brief, general health (Table 2) and specific focal\nassessments (Table 3) were separately scored, analyzed and finally added to form\na summation score. Summative scores added up to \xa0a maximum of 43 points with more points\nmeaning more deficits.', u'https://figshare.com/articles/Fig_8_behavior_temperature_bodyweight/3420901', [u'Animal Behaviour', u'Neuroscience'], []]
